Jazz Pharmaceuticals (JAZZ) EBITDA (2010 - 2026)
Jazz Pharmaceuticals' EBITDA was $427.3 million in Q2 2026, compared with -$512.4 million a year earlier and down 17.5% from the prior quarter.
Jazz Pharmaceuticals (JAZZ) EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Jazz Pharmaceuticals' EBITDA was $1.61 billion through Jun 30, 2026, up 323.7% year-over-year; for FY2025, it was $266.06 million, down 80.7% from FY2024.
- EBITDA shows a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
- In earlier years, EBITDA was $1.38 billion in FY2024 (+13.1%), $1.22 billion in FY2023 (+115.9%), $563.94 million in FY2022 (-22.0%) and $722.76 million in FY2021 (+10.1%).
- Quarterly EBITDA has moved between -$512.4 million (Q2 2025) and $518 million (Q1 2026) over five years.
- Compared with a year earlier, EBITDA was higher in four of the last six quarters, with growth averaging 59.0%.
- The best year-over-year quarter for EBITDA over five years was Q1 2026 (growth of 375.7%); the worst was Q1 2025 (a decline of 52.6%).
- Per Business Quant data, JAZZ's EBITDA in the three quarters before Q2 2026 was $518 million (Q1 2026), $433.7 million (Q4 2025) and $235.79 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn | 427.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 427.30 Mn |
| Mar 31, 2026 | 518.00 Mn |
| Dec 31, 2025 | 433.70 Mn |
| Sep 30, 2025 | 235.79 Mn |
| Jun 30, 2025 | -512.40 Mn |
| Mar 31, 2025 | 108.90 Mn |
| Dec 31, 2024 | 359.19 Mn |
| Sep 30, 2024 | 425.44 Mn |
| Jun 30, 2024 | 362.48 Mn |
| Mar 31, 2024 | 229.59 Mn |
| Dec 31, 2023 | 281.70 Mn |
| Sep 30, 2023 | 334.95 Mn |
| Jun 30, 2023 | 317.21 Mn |
| Mar 31, 2023 | 283.42 Mn |
| Dec 31, 2022 | -118.66 Mn |
| Sep 30, 2022 | 173.59 Mn |
| Jun 30, 2022 | 241.75 Mn |
| Mar 31, 2022 | 267.26 Mn |
| Dec 31, 2021 | 214.00 Mn |
| Sep 30, 2021 | 195.95 Mn |
Jazz Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=JAZZ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();